BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1769 related articles for article (PubMed ID: 31283911)

  • 21. Biodegradable PLGA implants containing doxorubicin-loaded chitosan nanoparticles for treatment of breast tumor-bearing mice.
    Kefayat A; Vaezifar S
    Int J Biol Macromol; 2019 Sep; 136():48-56. PubMed ID: 31195043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
    Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
    Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
    Srivastava S; Gupta S; Mohammad S; Ahmad I
    J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mn
    Xi J; Da L; Yang C; Chen R; Gao L; Fan L; Han J
    Int J Nanomedicine; 2017; 12():3331-3345. PubMed ID: 28479854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aptamer-conjugated PLGA nanoparticles for delivery and imaging of cancer therapeutic drugs.
    Hashemi M; Shamshiri A; Saeedi M; Tayebi L; Yazdian-Robati R
    Arch Biochem Biophys; 2020 Sep; 691():108485. PubMed ID: 32712288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.
    Aravind A; Jeyamohan P; Nair R; Veeranarayanan S; Nagaoka Y; Yoshida Y; Maekawa T; Kumar DS
    Biotechnol Bioeng; 2012 Nov; 109(11):2920-31. PubMed ID: 22615073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin.
    Dai Y; Xing H; Song F; Yang Y; Qiu Z; Lu X; Liu Q; Ren S; Chen X; Li N
    J Pharm Sci; 2016 Sep; 105(9):2949-2958. PubMed ID: 27209461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and optimization of doxorubicin loaded poly(lactic-co-glycolic acid) nanobubbles for drug delivery into HeLa cells.
    Deng L; Li L; Yang H; Li L; Zhao F; Wu C; Liu Y
    J Nanosci Nanotechnol; 2014 Apr; 14(4):2947-54. PubMed ID: 24734715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AS1411 aptamer/RGD dual functionalized theranostic chitosan-PLGA nanoparticles for brain cancer treatment and imaging.
    Chauhan M; Sonali ; Shekhar S; Yadav B; Garg V; Dutt R; Mehata AK; Goswami P; Koch B; Muthu MS; Singh RP
    Biomater Adv; 2024 Jun; 160():213833. PubMed ID: 38564997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Augmented anticancer efficacy of doxorubicin-loaded polymeric nanoparticles after oral administration in a breast cancer induced animal model.
    Jain AK; Swarnakar NK; Das M; Godugu C; Singh RP; Rao PR; Jain S
    Mol Pharm; 2011 Aug; 8(4):1140-51. PubMed ID: 21557558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gold nanorod-encapsulated biodegradable polymeric matrix for combined photothermal and chemo-cancer therapy.
    Chuang CC; Cheng CC; Chen PY; Lo C; Chen YN; Shih MH; Chang CW
    Int J Nanomedicine; 2019; 14():181-193. PubMed ID: 30613145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
    Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W
    Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AS1411 Aptamer-Decorated Biodegradable Polyethylene Glycol-Poly(lactic-co-glycolic acid) Nanopolymersomes for the Targeted Delivery of Gemcitabine to Non-Small Cell Lung Cancer In Vitro.
    Alibolandi M; Ramezani M; Abnous K; Hadizadeh F
    J Pharm Sci; 2016 May; 105(5):1741-1750. PubMed ID: 27039356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery.
    Taghavi S; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
    Cancer Lett; 2017 Aug; 400():1-8. PubMed ID: 28412238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
    Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation, characterisation and in vitro and in vivo evaluation of CD44-targeted chondroitin sulphate-conjugated doxorubicin PLGA nanoparticles.
    Liu P; Chen N; Yan L; Gao F; Ji D; Zhang S; Zhang L; Li Y; Xiao Y
    Carbohydr Polym; 2019 Jun; 213():17-26. PubMed ID: 30879657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
    He Y; Su Z; Xue L; Xu H; Zhang C
    J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surface modification of doxorubicin-loaded nanoparticles based on polydopamine with pH-sensitive property for tumor targeting therapy.
    Bi D; Zhao L; Yu R; Li H; Guo Y; Wang X; Han M
    Drug Deliv; 2018 Nov; 25(1):564-575. PubMed ID: 29457518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PLGA based particles as "drug reservoir" for antitumor drug delivery: characterization and cytotoxicity studies.
    Chronopoulou L; Domenici F; Giantulli S; Brasili F; D'Errico C; Tsaouli G; Tortorella E; Bordi F; Morrone S; Palocci C; Silvestri I
    Colloids Surf B Biointerfaces; 2019 Aug; 180():495-502. PubMed ID: 31103709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
    Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
    Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 89.